Prednisolone vs. Ciclosporine in Severe Atopic Eczema
NCT00445081 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 66
Last updated 2010-10-29
Summary
To investigate the comparative efficacy of Ciclosporine A and Prednisolone in adult patients with severe atopic dermatitis.
Conditions
Interventions
- DRUG
-
Prednisolone
- DRUG
-
Ciclosporine A
Sponsors & Collaborators
-
Technische Universität Dresden
lead OTHER
Principal Investigators
-
Jochen M Schmitt, MD MPH · Dpt. of Dermatology, TU Dresden, Fetscherstr 74, D-01307 Dresden
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-03-31
- Primary Completion
- 2009-09-30
- Completion
- 2010-01-31
Countries
- Austria
- Germany
Study Locations
More Related Trials
-
Ciclosporin Versus Alitretinoin for Severe Atopic Hand Dermatitis.
NCT01231854 ·Status: TERMINATED ·Phase: PHASE4
-
Long-term Study of Ciclosporin for Atopic Dermatitis
NCT00232063 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Oral Steroids on Skin Outcomes in Atopic Dermatitis
NCT02908698 ·Status: TERMINATED ·Phase: NA
-
Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema
NCT03026946 ·Status: UNKNOWN ·Phase: PHASE3
-
A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers
NCT00721331 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
NCT02087943 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of DNK333 in Atopic Dermatitis Patients
NCT01033097 ·Status: COMPLETED ·Phase: PHASE2
-
Distribution of Tacrolimus in Skin, Atopic Dermatitis
NCT00534508 ·Status: COMPLETED ·Phase: PHASE2
-
A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis
NCT00106496 ·Status: COMPLETED ·Phase: PHASE4
-
Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis
NCT00351052 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis
NCT01691209 ·Status: WITHDRAWN ·Phase: NA
-
Investigation of Flare and Remission in Subjects With Atopic Dermatitis
NCT03710044 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Trial of Antroquinonol in Patients With Atopic Dermatitis
NCT03622463 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population
NCT01137032 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis
NCT04212169 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis
NCT00691145 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 5 Days of Use on Subjects With Atopic Dermatitis
NCT05807113 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis
NCT02732314 ·Status: COMPLETED ·Phase: PHASE4
-
An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema
NCT03160248 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of OC000459 on Moderate to Severe Atopic Dermatitis
NCT02002208 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE Levels
NCT00616096 ·Status: COMPLETED ·Phase: NA
-
Oregano Ointment vs. Standard Treatment for Pediatric Atopic Dermatitis
NCT02289989 ·Status: TERMINATED ·Phase: NA
-
KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC)
NCT05454462 ·Status: COMPLETED ·Phase: PHASE1
-
Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis
NCT03361215 ·Status: RECRUITING
-
A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients
NCT03948334 ·Status: TERMINATED ·Phase: PHASE2